DePuy Synthes is recruiting for a Business & Commercial Excellence Lead located in Kibbutz Shefayim, Isreal.

Role Purpose

The Business & Commercial Excellence Leadis responsible fordriving commercial effectiveness, enabling data-driven decision making, and enhancing execution across DPS Israel. The role ensures strong alignment between strategy, performance management, and fieldexecutionto drive revenue growthandimprove sales efficiency whileleveragingdata analytics.

Key Responsibilities

• Supportcommercial excellence agenda, including KPI frameworks and performancemanagement,and translate it into actionable/ operational plans for strategic optimization.

• Support drivingsales force effectiveness (targeting, segmentation, incentive schemes)whileutilizingmarket intelligence and internal data toidentifygrowth opportunities

• Focalpoint in Business Plan andensure accuracy,efficiencyand transparency

• Develop and implementpricing,dashboards, analytics,BIand reporting tools

• Identifyperformance gaps andhighlight/recommend management teamcorrective actionsincluding adoption of tools (such as CRM) to improve efficiency

• Partner with Sales, Marketing, and Finance toalignstrategy,prioritiesand execution

• Support deployment of global and regional commercial initiatives locally

Education

• Bachelor's degree in business administration, Economics, IndustrialEngineeringor related field

• MBA – advantage

Experience

• 4-6+ years of experience in Commercial ExcellenceData Analyst Sales Operations / Consulting

• Experience in matrix/global organizations – advantage

• Healthcare / MedTech experience – advantage

Skills & Competencies

• Strong analytical and problem-solving skills

• Advancedproficiencyin Excel,BIand CRMtools (e.g., Power BI, Tableau, Monday)

• Ability to translate data into actionable insights

• Strong stakeholder management and influencing skills

• Strategic mindset with execution capability

Johnson & Johnson announced plans to separate our Orthopaedics business to establish a standalone orthopaedics company, operating as DePuy Synthes. The process of the planned separation is anticipated to be completed within 18 to 24 months, subject to legal requirements, including consultation with works councils and other employee representative bodies, as may be required, regulatory approvals and other customary conditions and approvals. Should you accept this position, it is anticipated that, following conclusion of the transaction, you would be an employee of DePuy Synthes and your employment would be governed by DePuy Synthes employment processes, programs, policies, and benefit plans. In that case, details of any planned changes would be provided to you by DePuy Synthes at an appropriate time and subject to any necessary consultation processes.